Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |
mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.061 | 0.7 |
mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.07 | 0.7 |
mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |